Anaesthesia for oesophagectomy

Current Opinion in Anaesthesiology

Volumn 20, Issue 1, 2007, Pages 15-20

  Pennefather, Stephen H ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

Anaesthesia; Oesophagectomy; Operative and postoperative management; Preoperative assessment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISPLATIN; CLOPIDOGREL; FLUOROURACIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OPIATE;

ADJUVANT CHEMOTHERAPY; DRUG ELUTING STENT; ENDOTRACHEAL INTUBATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; GASTROSCOPY; HUMAN; INDUCED HYPOTENSION; INTRACARDIAC THROMBOSIS; MEDICAL RESEARCH; MULTIMODALITY CANCER THERAPY; NUTRITION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURGICAL MORTALITY; THORAX EPIDURAL ANESTHESIA; TREATMENT OUTCOME;

ANESTHESIA; CHEMOTHERAPY, ADJUVANT; ESOPHAGECTOMY; HUMANS; NUTRITIONAL SUPPORT; PAIN, POSTOPERATIVE; PATIENT SELECTION; PERIOPERATIVE CARE; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 33846116184     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3280115895     Document Type: Review

References (88)

1. Souza RF, Spechler SJ. Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin 2005; 55:334-351.
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97:142-146.
3. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-831.
4. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143:199-211.
5. Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995; 87:104-109.
6. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58:588-590.
7. Torek F. The first successful case of resection of the thoracic portion of the oesophagus for carcinoma. Surg Gynecol Obstet 1913; 16:614.
8. Sweet RH. Surgical management of carcinoma of midthoracic esophagus. Preliminary report. N Engl J Med 1948; 233:1-7.
9. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. I: A critical review of surgery. Br J Surg 1980; 67:381-390.
10. Muller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77:845-857.
11. McCulloch P, Ward J, Tekkis PP, ASCOT group of surgeons; British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003; 327:1192-1197.
12. Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003; 75:217-222.
13. Miller JD, Jain MK, de Gara CJ, et al. Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol 1997; 65:20-21.
14. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003; 349:2117-2127.
15. van Lanschot JJ, Hulscher JB, Buskens CJ, et al. Hospital volume and hospital mortality for esophagectomy. Cancer 2001; 91:1574-1578.
16. Metzger R, Bollschweiler E, Vallbohmer D, et al. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 2004; 17:310-314.
17. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 2003; 75:337-341.
18. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128-1137.
19. Sherry K. Management of patients undergoing oesophagectomy. In: Gray AJG, Hoile RTW, Ingram GS, Sherry KM, editors. The report of the national confidential enquiry into perioperative deaths 1996/1997. London: The National Confidential Enquiry into Perioperative Deaths; 1998. pp. 57-61.
20. Law S, Wong J. Use of minimally invasive oesophagectomy for cancer of the oesophagus. Lancet Oncol 2002; 3:215-222.
21. Law S, Wong J. Current management of esophageal cancer. J Gastrointest Surg 2005; 9:291-310. The authors provide a current balanced review of the surgical management of oesophageal cancer.
22. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339:1979-1984.
23. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359:1727-1733.
24. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. The Cochrane library. Chichester, UK: John Wiley & Sons Ltd; 2004.
25. Wright CD. Esophageal cancer surgery in 2005. Minerva Chir 2005; 60:431-444. A useful review.
26. Law SY, Fok M, Wong J. Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg 1994; 18:339-346.
27. Ferguson MK, Martin TR, Reeder LB, Olak J. Mortality after esophagectomy: risk factor analysis. World J Surg 1997; 21:599-603.
28. Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002; 123:661-669.
29. Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 2004; 78:1170-1176.
30. Law S, Wong KH, Kwok KF, et al. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 2004; 240:791-800.
31. Abunasra H, Lewis S, Beggs L, et al. Predictors of operative death after oesophagectomy for carcinoma. Br J Surg 2005; 92:1029-1033.
32. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85:840-844.
33. Tandon S, Batchelor A, Bullock R, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth 2001; 86:633-638.
34. Whooley BP, Law S, Murthy SC, et al. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001; 233:338-344.
35. Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91:943-947.
36. Lerut T, Nafteux P, Moons J, et al. Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junction. Eur J Surg Oncol 2005; 31:587-594.
37. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
38. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20.
39. Gawaz M, Neumann FJ, Ott I, et al. Platelet activation and coronary stent implantation: effect of antithrombotic therapy. Circulation 1996; 94:279-285.
40. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364:1519-1521.
41. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288-1294.
42. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing noncardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42:234-240.
43. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
44. Yusuf S, Zhao F, Mehta SR, et al. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494-502.
45. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
46. Spahn DR, Howell SJ, Delabays A, Chassot PG. Coronary stents and perioperative antiplatelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth 2006; 96:675-677.
47. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93:573-580.
48. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107:1848-1851.
49. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105:1257-1267.
50. Brady AR, Gibbs JS, Greenhalgh RM, et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005; 41:602-609.
51. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major noncardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332:1482-1485.
52. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331:313-321.
53. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353:349-361.
54. Eichhorn EJ. Beta-blocker withdrawal: the song of Orpheus. Am Heart J 1999; 138:387-389.
55. Pennefather SH, Russell GN. Placement of double lumen tubes: time to shed light on an old problem. Br J Anaesth 2000; 84:308-310.
56. Agnew NM, Kendall JB, Akrofi M, et al. Gastroesophageal reflux and tracheal aspiration in the thoracotomy position: should ranitidine premedication be routine? Anesth Analg 2002; 95:1645-1649.
57. Sanjay PS, Miller SA, Corry PR, et al. The effect of gel lubrication on cuff leakage of double lumen tubes during thoracic surgery. Anaesthesia 2006; 61:133-137.
58. Shackcloth MJ, McCarron E, Kendall J, et al. Randomized clinical trial to determine the effect of nasogastric drainage on tracheal acid aspiration following oesophagectomy. Br J Surg 2006; 93:547-552. Reveals the remarkably high incidence of tracheal acid aspiration after oesophagectomy.
59. Alanezi K, Urschel JD. Mortality secondary to esophageal anastomotic leak. Ann Thorac Cardiovasc Surg 2004; 10:71-75.
60. Ikeda Y, Niimi M, Kan S, et al. Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J Thorac Cardiovasc Surg 2001; 122:1101-1106.
61. Boyle NH, Pearce A, Hunter D, et al. Intraoperative scanning laser Doppler flowmetry in the assessment of gastric tube perfusion during esophageal resection. J Am Coll Surg 1999; 188:498-502.
62. Bonica JJ. Autonomic innervation of the viscera in relation to nerve block. Anaesthesiology 1968; 29:793-813.
63. Page RD, Shackcloth MJ, Russell GN, Pennefather SH. Surgical treatment of anastomotic leaks after oesophagectomy. Eur J Cardiothorac Surg 2005; 27:337-343.
64. Griffin SM, Lamb PJ, Dresner SM, et al. Diagnosis and management of mediastinal leak following radical oesophagectomy. Br J Surg 2001; 88:1346-1351.
65. Iannettoni MD, Whyte RI, Orringer MB. Catastrophic complications of the cervical esophagogastric anastomosis. J Thorac Cardiovasc Surg 1995; 110:1493-1501.
66. Shackford SR, Virgilio RW, Peters RM. Early extubation versus prophylactic ventilation in the high risk patient: a comparison of postoperative management in the prevention of respiratory complications. Anesth Analg 1981; 60:76-80.
67. Dos Santos CC, Slutsky AS. Invited review: mechanisms of ventilator-induced lung injury: a perspective. J Appl Physiol 2000; 89:1645-1655.
68. Caldwell MT, Murphy PG, Page R, et al. Timing of extubation after oesophagectomy. Br J Surg 1993; 80:1537-1539.
69. Watson A, Allen PR. Influence of thoracic epidural analgesia on outcome after resection for esophageal cancer. Surgery 1994; 115:429-432.
70. Terai T, Yukioka H, Fujimori M. Administration of epidural bupivacaine combined with epidural morphine after esophageal surgery. Surgery 1997; 121:359-365.
71. Yap FH, Lau JY, Joynt GM, et al. Early extubation after transthoracic oesophagectomy. Hong Kong Med J 2003; 9:98-102.
72. Chandrashekar MV, Irving M, Wayman J, et al. Immediate extubation and epidural analgesia allow safe management in a high-dependency unit after two-stage oesophagectomy: results of eight years of experience in a specialized upper gastrointestinal unit in a district general hospital. Br J Anaesth 2003; 90:474-479.
73. Bartels H, Stein HJ, Siewert JR. Early extubation vs late extubation after esophagus resection: a randomized, prospective study [in German]. Langenbecks Arch Chir Suppl Kongressbd 1998; 115:1074-1076.
74. Katz J, Jackson M, Karanagh, et al. Acute pain after thoracic surgery predicts long term postthoracotomy pain. Clin J Pain 1996; 12:50-55.
75. d'Amours RH, Riegler FX, Little AG. Pathogenesis and management of persistent postthoracotomy pain. Chest Surg Clin North Am 1998; 8:703-722.
76. Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg 2002; 94:11-15.
77. Rudin A, Flisberg P, Johansson J, et al. Thoracic epidural analgesia or intravenous morphine analgesia after thoracoabdominal esophagectomy: a prospective follow-up of 201 patients. J Cardiothorac Vasc Anesth 2005; 19:350-357.
78. Flisberg P, Tornebrandt K, Walther B, Lundberg J. Pain relief after esophagectomy: thoracic epidural analgesia is better than parenteral opioids. J Cardiothorac Vasc Anesth 2001; 15:282-287.
79. Cense HA, Lagarde SM, de Jong K, et al. Association of no epidural analgesia with postoperative morbidity and mortality after transthoracic esophageal cancer resection. J Am Coll Surg 2006; 202:395-400. A retrospective review of a homogeneous group of patients in all of whom a thoracic epidural was attempted. In almost half of patients the thoracic epidural was not inserted or removed within 48 h; the remaining patients had a thoracic epidural for over 48 h. This review provides the best available evidence for the use of a thoracic epidural following transthoracic oesophagectomy.
80. Smedstad KG, Beattie WS, Blair WS, Buckley DN. Postoperative pain relief and hospital stay after total esophagectomy. Clin J Pain 1992; 8:149-153.
81. Rigg JR. Does regional block improve outcome after surgery? Anaesth Intensive Care 1991; 19:404-411.
82. Liu S, Carpenter RL, Neal JM. Epidural anesthesia and analgesia: their role in postoperative outcome. Anesthesiology 1995; 82:1474-1506.
83. Volk T, Schenk M, Voigt K, et al. Postoperative epidural anesthesia preserves lymphocyte, but not monocyte, immune function after major spine surgery. Anesth Analg 2004; 98:1086-1092.
84. Yokoyama M, Itano Y, Katayama H, et al. The effects of continuous epidural anesthesia and analgesia on stress response and immune function in patients undergoing radical esophagectomy. Anesth Analg 2005; 101:1521-1527.
85. Baigrie RJ, Devitt PG, Watkin DS. Enteral versus parenteral nutrition after oesophagogastric surgery: a prospective randomized comparison. Aust N Z J Surg 1996; 66:668-670.
86. Aiko S, Yoshizumi Y, Sugiura Y, et al. Beneficial effects of immediate enteral nutrition after esophageal cancer surgery. Surg Today 2001; 31:971-978.
87. Watters JM, Kirkpatrick SM, Norris SB, et al. Immediate postoperative enteral feeding results in impaired respiratory mechanics and decreased mobility. Ann Surg 1997; 226:369-377.
88. Page RD, Oo AY, Russell GN, Pennefather SH. Intravenous hydration versus naso-jejunal enteral feeding after esophagectomy: a randomised study. Eur J Cardiothorac Surg 2002; 22:666-672.